These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28660415)

  • 41. Clinical characteristics and outcomes of septic patients with new-onset atrial fibrillation.
    Christian SA; Schorr C; Ferchau L; Jarbrink ME; Parrillo JE; Gerber DR
    J Crit Care; 2008 Dec; 23(4):532-6. PubMed ID: 19056018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacological cardioversion of atrial fibrillation].
    Ehrlich JR; Hohnloser SH
    Z Kardiol; 2005 Jan; 94(1):14-22. PubMed ID: 15668825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
    de Luca I; Sorino M; Del Salvatore B; de Luca L
    Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly.
    Elesber AA; Rosales AG; Herges RM; Shen WK; Moon BS; Malouf JF; Ammash NM; Somers V; Hodge DO; Gersh BJ; Hammill SC; Friedman PA
    Eur Heart J; 2006 Apr; 27(7):854-60. PubMed ID: 16455671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anticoagulation in patients with atrial fibrillation].
    Mügge A
    Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atrial fibrillation: current therapeutic approaches.
    Deantonio HJ; Movahed A
    Am Fam Physician; 1992 Jun; 45(6):2576-84. PubMed ID: 1350700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery.
    Maras D; Bosković SD; Popović Z; Nesković AN; Kovacević S; Otasević P; Marinković J; Vuk L; Borzanović M; Nastasić S; Jovanović T; Bojić M; Babić R; Popović AD
    Am Heart J; 2001 May; 141(5):E8. PubMed ID: 11320383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.
    Falsetti L; Viticchi G; Tarquinio N; Silvestrini M; Capeci W; Balloni A; Catozzo V; Gentile A; Pellegrini F
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):636-41. PubMed ID: 24978663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New onset atrial fibrillation in patients hospitalized with sepsis : is there an indication for anticoagulation ?].
    Dominati A; Serratrice J; Namdar M
    Rev Med Suisse; 2020 Oct; 16(711):1988-1994. PubMed ID: 33085255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-hospital Outcomes of Patients with Septic Shock and Underlying Chronic Atrial Fibrillation: A Propensity Matched Analysis from A National Dataset.
    Vindhyal MR; Vasudeva R; Pothuru S; James Kallail K; Choi W; Ablah E; Hockstad E; Shah Z; Gupta K
    J Intensive Care Med; 2023 May; 38(5):425-430. PubMed ID: 36205076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe sepsis and septic shock in patients with pre-existing non-cardiac pulmonary hypertension: contemporary management and outcomes.
    Tsapenko MV; Herasevich V; Mour GK; Tsapenko AV; Comfere TB; Mankad SV; Cartin-Ceba R; Gajic O; Albright RC
    Crit Care Resusc; 2013 Jun; 15(2):103-9. PubMed ID: 23931041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for atrial fibrillation recurrence: a literature review.
    Vizzardi E; Curnis A; Latini MG; Salghetti F; Rocco E; Lupi L; Rovetta R; Quinzani F; Bonadei I; Bontempi L; D'Aloia A; Dei Cas L
    J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):235-53. PubMed ID: 23114271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Problems with anti-arrhythmia therapy in atrial fibrillation].
    Breithardt G; Kottkamp H; Haverkamp W; Hindricks G; Fetsch T; Borggrefe M
    Z Kardiol; 1994; 83 Suppl 5():63-9. PubMed ID: 7846947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
    Airaksinen KE; Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Biancari F; Hartikainen JE
    J Am Coll Cardiol; 2013 Sep; 62(13):1187-92. PubMed ID: 23850908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Reduction of atrial fibrillation. New concepts, new strategies].
    Lardoux H; Lechat P; Isnard R
    Presse Med; 1995 Dec; 24(38):1820-3. PubMed ID: 8545434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of atrial fibrillation in the acute setting.
    Chenoweth J; Diercks DB
    Curr Opin Crit Care; 2012 Aug; 18(4):333-40. PubMed ID: 22622515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological management of atrial fibrillation: an update.
    Hohnloser SH; Li YG; Bender B; Grönefeld G
    J Cardiovasc Pharmacol Ther; 2000 Jan; 5(1):11-6. PubMed ID: 10687669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.